Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database

BACKGROUND: Memantine, an NMDA receptor antagonist, is used for the treatment of Alzheimer’s disease. There is a caution to refrain from administrating memantine in combination with some specific drugs such as amantadine or dextromethorphan due to potential interactions that might augment the advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kenichiro, Mano, Tatsuo, Iwata, Atsushi, Toda, Tatsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461680/
https://www.ncbi.nlm.nih.gov/pubmed/34151816
http://dx.doi.org/10.3233/JAD-210524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461680/
https://www.ncbi.nlm.nih.gov/pubmed/34151816
http://dx.doi.org/10.3233/JAD-210524

Ejemplares similares